Peripheral T Cell Lymphoma, Unspecified
4 clinical trials · Condition
◉ Watch Peripheral T Cell Lymphoma, Unspecified
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma (NCT05208853) | Zhejiang University | 2022-02-10 |
| RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas (NCT01198665) | Samsung Medical Center | 2010-07-01 |
| Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas (NCT00704691) | University of Alabama at Birmingham | 2008-06-01 |
| Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP (NCT00725231) | University of Göttingen | 2008-02-01 |
Track Peripheral T Cell Lymphoma, Unspecified automatically
Every clearance here is in the API, with alerts when new ones post.